首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Journal of alzheimers disease reports

缩写:

ISSN:N/A

e-ISSN:2542-4823

IF/分区:2.8/Q3

文章目录 更多期刊信息

共收录本刊相关文章索引682
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Subhrangshu Das,Priyanka Panigrahi,Saikat Chakrabarti Subhrangshu Das
Background: The total number of people with dementia is projected to reach 82 million in 2030 and 152 in 2050. Early and accurate identification of the underlying causes of dementia, such as Alzheimer's disease (AD) is of...
Chaur-Jong Hu,Ming-Jang Chiu,Ming-Chyi Pai et al. Chaur-Jong Hu et al.
Background: In Alzheimer's disease (AD), cognitive impairment begins 10-15 years later than neurodegeneration in the brain. Plasma biomarkers are promising candidates for assessing neurodegeneration in people with normal ...
Umma Habiba,Makiko Ozawa,James K Chambers et al. Umma Habiba et al.
Background: Canine cognitive dysfunction (CCD) is a progressive syndrome recognized in mature to aged dogs with a variety of neuropathological changes similar to human Alzheimer's disease (AD), for which it is thought to ...
Rónán O&#x;Caoimh,Mareeta Calnan,Arup Dhar et al. Rónán O&#x;Caoimh et al.
Background: Although caregiver burden is common among carers of people with dementia, little is known about its prevalence and predictors among caregivers of patients attending memory clinics. ...
Elena L Paley Elena L Paley
The author discussed recently the possible molecular mechanisms that cause the COVID-19 disease symptoms. Here the analysis of the recent experimental data supports the hypothesis that production of the gut microbial tryptamine can be induc...
Abdelrahman Elwishahy,Khatia Antia,Sneha Bhusari et al. Abdelrahman Elwishahy et al.
Background: Alzheimer's disease (AD) is a chronic neurodegenerative disease that accounts for more than 50% of all dementia cases worldwide. There is wide consensus on the risk factors of AD; however, a clear etiology rem...
Vaitsa Giannouli,Magda Tsolaki Vaitsa Giannouli
Neuropsychological assessment in amnestic mild cognitive impairment (aMCI) becomes complicated when education-literacy is taken into consideration. This study sought to explore the potential influence of literacy/illiteracy and education on...
Ismaeel Yunusa,Saud Alsahali,Amey Rane et al. Ismaeel Yunusa et al.
Background: Pharmacological treatment of Alzheimer's disease (AD) involves symptomatic improvement of cognition using cholinesterase inhibitors (ChEIs) and memantine. The cost-effectiveness of these medications will guide...
Md A Hakim,Erik J Behringer Md A Hakim
Background: As the sixth-leading cause of death in the United States, Alzheimer's disease (AD) entails deteriorating endothelial control of blood flow throughout the brain. In particular, reduced inward-rectifying K+ (KIR...